Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Neuralgia, Pain in extremity, Pyrexia
Clinical narrative: Flare-up of nerve pain in various body areas; Flare-up of eczema arms; Inability to raise arms due to painful armpits; Low grade fever; Headache; Sore arm; Tired; Joint pain; Decreased appetite; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 75 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 28Sep2021 13:15 (Lot number: FE3592) at the age of 75 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "hemiplegic migraine" (unspecified if ongoing); "osteoarthritis" (ongoing); "Rt.knee replacement" (not ongoing); "Rt. wrist fx repair" (not ongoing); "hypothyroid" (ongoing); "osteopenia" (unspecified if ongoing); "overactive bladder" (unspecified if ongoing); "skin Cancer" (ongoing); "seasonal allergies" (ongoing); "Migraine" (ongoing), notes: Onset date: Before 1979 (early 90 s) , none at time of event; "Hamstring injury" (ongoing); "Nerve pain", start date: Mar2009 (unspecified if ongoing), notes: Stop date: Intermittent (2017, 2020). Concomitant medication(s) included: LEVOTHYROXINE taken for hypothyroidism (ongoing); ATORVASTATIN taken for blood cholesterol increased, start date: 2018 (ongoing); TRAMADOL taken for migraine (ongoing); ZOLPIDEM taken for insomnia (ongoing); LOSARTAN taken for blood pressure increased (ongoing). Past drug history included: Known allergies: codeine, reaction(s): "Known Allergies: codeine"; Known allergies: lactose sensitive, reaction(s): "Known Allergies: lactose sensitive". Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: Unknown., Location: Arm Left, Administration Time: 12:00 PM, Route: IM), administration date: 19Feb2021, when the patient was 74 years old, for COVID-19 immunization; Bnt162b2 (Dose Number: 2, Batch/Lot No: Unknown., Administration Time: 13:00 , Route: IM), administration date: 12Mar2021, when the patient was 74 years old, for COVID-19 immunization.  The following information was reported: NEURALGIA (non-serious) with onset 28Sep2021 21:00, outcome "recovered" (Sep2021), described as "Flare-up of nerve pain in various body areas"; ECZEMA (non-serious) with onset 28Sep2021 21:00, outcome "recovered" (Sep2021), described as "Flare-up of eczema arms"; AXILLARY PAIN (non-serious) with onset 28Sep2021 21:00, outcome "recovered" (Sep2021), described as "Inability to raise arms due to painful armpits"; PYREXIA (non-serious) with onset 28Sep2021 21:00, outcome "recovered" (Sep2021), described as "Low grade fever"; HEADACHE (non-serious) with onset 28Sep2021 21:00, outcome "recovered" (Sep2021), described as "Headache"; PAIN IN EXTREMITY (non-serious) with onset 28Sep2021 21:00, outcome "recovered" (Sep2021), described as "Sore arm"; FATIGUE (non-serious) with onset 28Sep2021 21:00, outcome "recovered" (Sep2021), described as "Tired"; ARTHRALGIA (non-serious) with onset 28Sep2021 21:00, outcome "recovered" (Sep2021), described as "Joint pain"; DECREASED APPETITE (non-serious) with onset 28Sep2021 21:00, outcome "recovered" (Sep2021), described as "Decreased appetite". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of neuralgia, eczema, axillary pain, pyrexia, headache, pain in extremity, fatigue, arthralgia, decreased appetite.  Additional information: Patient did not received any other vaccine within 4 weeks of Covid-19 vaccine. Patient was not diagnosed with Covid-19 prior to vaccination. Patient was not tested for Covid-19 since vaccination. As already reported 28Sep2021 9 PM left arm tender. 29Sep2021 with headache. On awakening in AM nerve pain from hamstring injury resurfaced. Eczema resurfaced. 30Sep2021 fever subsided with other symptoms although remained tired with decrease appetite, some joint pain for another couple days.  No follow-up attempts are possible. No further information is expected.